Literature DB >> 25976640

Response to 'Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the U.S.A.'.

A Lotery1, S Regnier2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25976640      PMCID： PMC4541351          DOI： 10.1038/eye.2015.69

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  2 in total

1.  Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the U.S.A.

Authors:  D Călugăru; M Călugăru
Journal:  Eye (Lond)       Date:  2015-05-15       Impact factor: 3.775

2.  The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity.

Authors: 
Journal:  Ophthalmology       Date:  2014-01-23       Impact factor: 12.079
  2 in total
  1 in total

1.  Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Authors:  S Nghiem-Buffet; S Baillif; S Regnier; A Skelly; N Yu; A Sodi
Journal:  Eye (Lond)       Date:  2017-02-24       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.